Search strategy and study selection We conducted a comprehensive search through PubMed, Scopus, and Web of Science databases to identify pertinent studies from their inception until March 2024
CLINICAL EVIDENCE OF THE USE OF GLP-1RAs IN BAD TREATMENT Two patients experiencing complete remission of BAD symptoms after initiating liraglutide treatment for type 2 diabetes and obesity, respectively (15), inspired us to compare the effect of liraglutide and the current standard-of-care treatment of BAD, the bile acid sequestrant colesevelam, in patients with idiopathic or postcholecystectomy BAD in a 6-week double-dummy, double-blind RCT (21)
For example, nicotine patches help with smoking cessation, whereas fentanyl patches deliver controlled doses for pain relief
start with a lower dose and increase gradually based on tolerance
How often do you need to take Mounjaro compared to Ozempic for weight loss
PLEASE NOTE: The link to the Highmark RxDC Survey provided in the blast below is broken
